Article by QFINITY’s Senior Executive Consultant ranks 3rd most read article in Clinical Supplier Leader

We are pleased to announce that Frank Henrichmann’s article was the third most-read article on the Clinical Supplier Leader platform in October. The topic of the article was ‘Massive Data, More Decentralisation Drive Updates To ISPE GAMP Guide’. This underscores the article’s relevance to the clinical research and development community.

The article highlights the need for a new version of the ISPE GAMP Guide. Mr. Henrichmann addresses the far-reaching changes in the clinical data landscape. He focuses on risk-based system validations under Good Clinical Practice. He offers insights and recommendations to help clinical trial stakeholders overcome new challenges and make the most of modern data architectures.

At QFINITY, we see the strong response to Mr. Henrichmann’s article as confirmation of how much pharmaceutical and clinical research depend on current, practical information. It also shows how much the dialogue about innovative, decentralized data systems and adapting to new regulatory requirements matters.

Congratulations to Frank Henrichmann on this recognition of his work, which gives the industry valuable food for thought!

You can find the full interview here. More information on the Clinical Supply Leader placement is available here.

Check our News page for more about QFINITY’s work.
Read the article at Clinical Leader (clinicalleader.com)↗